Invention is an essential feature of business. The best inventions are created when you mix talented people playing to their strengths in an environment of open collaboration, working in partnership with clients and suppliers with a clear focus on commercial goals.
Exciting and varied work that makes a difference. A collaborative culture where you can take on complex technical challenges and deliver commercial impact. That's life at TTP.
Biomedical imaging and diagnostic platforms increasingly demand stable detection reagents and quantifiable signal output. Upconversion nanoparticles fit the bill and, in the hands of Wenshu Xu and Verity Jackson, allow for multiplex biomarker detection.
From temperature sensors and connected toasters to security cameras and smart cars, it's easy to assume that the correct level of security for IoT devices is the highest level of security, but this isn't necessarily the case, says Brendan Ronayne.
With Beyond Visual Line of Sight (BVLOS) operations just over the horizon, future enterprise drones could vastly improve industrial productivity. But to offer products with the right capabilities, drone manufacturers must guide the development of a common underlying technology platform for their target market segments, says Vidhya Sridhar.
The satellite and telecoms industries have committed to the future convergence of terrestrial and non-terrestrial telecommunications networks. A world of global hybrid connectivity based on 5G standards is coming into sight, and so is a new industry ecosystem.
TTP was asked by the UK Government to assist in the rapid development and manufacture of ventilators to address the anticipated rise in demand during the Covid-19 pandemic.
TTP plc (TTP), a leading independent technology and product development company, has announced today that it has partnered with ODx (ODx Innovations Ltd), a company committed to developing a system for assessing urinary tract infections (UTIs). The collaboration is focussed on bringing ODx’ system to market through TTP’s Desktop Biology service.
TTP is working in partnership with Dyson on a new ventilator, CoVent, which aims to increase the number of ventilators available to the NHS. This work is part of a wider initiative that includes other, novel ventilator designs that are being pursued in parallel. These ventilators are urgently needed for treating COVID-19 patients suffering with Acute Respiratory Distress Syndrome (ARDS).
On 13th March, a group of leading medical device development companies from Cambridge was asked by the UK Government to assist in the rapid development and manufacture of ventilators to meet increased hospital requirements, caused by COVID-19.
